Albumin-myosteatosis gauge as a novel prognostic risk factor in patients with non-metastatic colorectal cancer.

Yerim KimJae-Hoon LeeEun-Suk ChoHye Sun LeeSu-Jin ShinEun Jung ParkSeung Hyuk BaikKang Young LeeJeong Hyun Kang

Published in: Journal of cachexia, sarcopenia and muscle (2023)

In patients with stage I-III CRC, AMG is a meaningful predictor of survival, with superior prognostic value compared to SMI, SMD or albumin alone. Further studies are needed to determine their significance in different ethnic groups.

Keyphrases

metastatic colorectal cancer
risk factors
ultrasound guided
case control
free survival